Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.
Cerebrovascular disease and stroke are very common at all stages of chronic kidney disease (CKD), likely representing both shared risk factors as well as synergy among risk factors. More subtle ischemic brain lesions may be particularly common in the CKD population, with subtle manifestations including cognitive impairment. For individuals with nondialysis CKD, the prevention, approach to, diagnosis, and management of stroke is similar to the general, non-CKD population. For individuals with end-stage renal disease, far less is known regarding strategies to prevent stroke. Stroke prophylaxis using warfarin in dialysis patients with atrial fibrillation in particular remains of uncertain benefit. End-stage renal disease patients can be managed aggressively in the setting of acute stroke. Outcomes after stroke at all stages of CKD are poor, and improving these outcomes should be the subject of future clinical trials.
Division of Nephrology, Tufts Medical Center, Boston, MA.
Taimur
T
Dad
Division of Nephrology, Tufts Medical Center, Boston, MA. Electronic address: dweiner@tuftsmedicalcenter.org.
Daniel E
DE
Weiner
D019468:Disease Management; D006801:Humans; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy*; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*
Chronic kidney disease; dialysis; end stage renal disease; hypertension; stroke; tissue plasminogen activator